Related Experiment Video
Updated: Nov 2, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery
Katarina Braune1,2, Katarzyna Anna Gajewska3,4, Axel Thieffry5
1Charité - Universitätsmedizin Berlin, Department of Paediatric Endocrinology and Diabetes, Berlin, Germany.
People with diabetes are increasingly using open-source automated insulin delivery (AID) systems due to unmet needs with commercial options. This technology improves glycemic control and reduces complication risks.
Area of Science:
- Diabetes Technology
- Endocrinology
- Health Informatics
Background:
- Commercial automated insulin delivery (AID) systems are not universally accessible or affordable.
- User-driven, open-source AID systems are gaining popularity among individuals with diabetes.
- There is a growing need to understand the motivations behind adopting these personalized systems.
Purpose of the Study:
- To investigate the motivations driving individuals with diabetes and their caregivers to build and use open-source AID systems.
- To explore the self-reported clinical outcomes associated with the use of personalized open-source AID.
- To provide insights into the evolving landscape of diabetes technology.
Main Methods:
- A cross-sectional, web-based survey was administered to participants globally.
- The survey assessed personal motivations for using open-source AID.
- Self-reported clinical outcomes, including glycated hemoglobin (HbA1c) and time in range, were evaluated.
Main Results:
- Key motivations included improving glycemic outcomes, reducing complication risks, and decreasing interaction with diabetes technology.
- Participants reported significant improvements in HbA1c (7.14% to 6.24%) and time in range (62.96% to 80.34%).
- Caregivers frequently cited improved sleep quality for themselves and their children as a primary motivator.
Conclusions:
- Open-source AID systems address unmet needs for people with diabetes.
- These systems demonstrate potential for improved clinical outcomes and offer valuable insights for healthcare professionals and policymakers.
- The study highlights the growing importance and effectiveness of personalized, open-source diabetes management solutions.
Related Concept Videos
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Secretory Vesicles
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

